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Abstract
Mitragyna speciosa (MS) which is known as ‘”Ketum” in Malaysia and 
“Kratom” in Thailand is a tropical plant indigenous to Southeast Asia. 
The leaves of MS have been used by natives of these countries for their 
opium-like effects and cocaine-like stimulant activities to overcome 
fatigue, enhance tolerance to hard work, prolong the duration of sexual 
intercourse and increase libido in males. However, no scientific studies 
have been carried out to assess the effect of MS consumption on the 
quality of sperm in animals or man. In this study, the effect of short-
term ingestion of MS on the quality of sperm in mice was investigated. 
Forty mice were divided into 5 groups; 2 controls and 3 treatments. The 
negative control group received 0.9% sodium chloride (NaCl, 10 mL/
kg) while the positive control received clomiphene (25 mg/70 kg). The 
respective treatment groups received either 50, 100 and 200 mg/kg of MS 
extract. The drugs and extracts were administered orally once daily for 
14 d. The results showed an increase in the number of sperms in groups 
treated with MS. The morbidity rates of the sperm in groups treated with 
MS were markedly lower than that of the control groups. In addition, 
marked deformity in the sperm in the form of swelling at the tail was 
observed in the groups treated with MS. In conclusion, mice treated with 
MS showed an increase in the number of sperm count in spite of defect 
in sperm morphology and reduced sperm motility.
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Introduction
In humans, male infertility accounts for an estimated 40-50% of the factors 
responsible for sexual dysfunction and failure of pregnancy in women (Brugh and 
Lipschultz, 2004). Examples of available treatments currently used to correct this 
6th Proceedings of the Seminar on Veterinary Sciences52
condition include Vitamin E prescription to counter the oxidative stress associated 
with sperm DNA damage and reduced sperm motility, a hormone-antioxidant 
combination and off-label use of clomiphene citrate, an anti-estrogen drug used to 
treat fertility problem in females. 
 Clomiphene citrate for example, has been shown to correct hypogonadism 
produced by functional suppression of pituitary gonadotropin with a modest effect 
on sexual function. In addition, patients treated with clomiphene citrate showed 
sexual improvement with significant increases in the luteinizing hormone (LH) 
and level of free testosterone (Guay et al., 2003). However, clomiphene citrate 
is currently under trials for use in men and has not been approved by the U.S 
Food and Drug Administration for use in humans. Moreover, any enhancement of 
fertility in men could only be observed after 3-6 months of continuous clomiphene 
citrate consumption. Therefore, the need to find an alternative drug or herb which 
may enhance fertility rate in males in shorter period remains the focus of many 
reproductive researches worldwide. Mitragyna speciosa (MS) plant, for example, 
has been used in folklore medicine to treat such cases. 
 Mitragyna speciosa is a tropical plant indigenous to Southeast Asia especially 
in Thailand, Peninsular Malaysia and Indonesia. It has been reported that, MS 
taken as concoction may prolong the duration of sexual intercourse in humans 
although the claim has not been scientifically proven. In addition, consumption of 
MS leaves has been reported to increase the energy level in labourers and libido in 
male subjects. However, no scientific studies have been done to assess the effect 
of MS consumption on the sperm quality of males in general. Thus, the aim of 
this study was to evaluate the quality of sperm in mice treated with the crude 
methanolic extract of Mitragyna speciosa to provide pharmacological basis for 
treatment of male fertility disorder.
Materials and methods
Experimental animals
Mice were kept under standard laboratory conditions (12h-light: 12h-dark) with an 
environmental temperature of 24-25˚C. Feed and water were supplied ad-libitum. 
The animals were acclimatized for one week prior to the experiment. Fifty healthy 
male BALB/c mice (3-4 weeks old, weighing 20-25 g) were divided randomly 
into five groups. The negative control group received sodium chloride (0.9%, 10 
mL/kg), positive control group received clomiphene (25 mg/70kg) and another 
three groups were treated with MS methanolic extract (MSM) at the dosage of 
50, 100 and 200 mg/kg, respectively. Drugs and extracts were administered orally 
once daily for 14 consecutive days via intra-gastric route using an oral gavage 
needle attached to a syringe. Mice were euthanized on Day 14 and sperm samples 
were harvested from each mouse immediately after euthanasia. The quality of each 
sperm samples was evaluated using standard evaluation techniques. 
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Sperm evaluation
One drop of sperm suspension was placed on a microscope slide using a pipette. 
The slide was then covered with a 22 x 22 mm coverslip. Microscopic fields were 
observed at 400x magnification using a standard microscope and the percentage 
of sperm motility was determined. Sperm numbers were calculated by using a 
Haemacytometer and the concentration was expressed as x106 sperm/mL sample. 
In order to observe the effect of various treatments on sperm morphology, one drop 
of sperm suspension was smeared onto a slide and stained with eosin-nigrosin. 
Samples were observed under the light microscope for presence of deformities and 
other abnormalities.   
Statistical analysis
The one-way analysis of variance (ANOVA), followed by Tukey’s test, was used to 
compare differences between treatments. The student’s t-test was used to compare 
differences between 2 groups. Data are expressed as mean ± SEM. Differences 
were considered to reach statistical significance when P<0.05. 
Results
The effect of various treatments on the sperm count of mice is shown in Figure 
1. Results showed that mice treated with 100 mg/kg of extract produced marked 
increase in sperm count (1.96 ± 0.164 x 106 sperm/mL) as compared to negative 
(0.9% NaCl) and positive (clomiphene) control groups. However, the group that 
was treated with 200 mg/kg showed a sperm count of 1.8 ± 0.07 x 106 sperm/mL, 
which is almost similar to the group treated with 100 mg/kg extract.  Despite this, 
there was no significant difference between these groups as indicated by the t-Test. 
 The effects of various treatments on mice sperm motility is shown in Figure 
2. The group that received 100 mg/kg of extract showed a 79 ± 1.01% sperm 
motility. There was no significant difference in the percentage of sperm motility 
as compared to negative (0.9% NaCl) and positive (clomiphene) groups except for 
the group treated with extract at the dosage of 50 mg/kg.
 In Figure 3, the group that was treated with 100 mg/kg MSM showed an 
increase in the weight of testis (0.1 ± 0.0 mg) when compared to the group treated 
with 0.9% NaCl (0.015 ± 0.002 mg). However, there was no significant difference 
between groups treated with 100 and 200 mg/kg of extract. 
 In Figure 4, no apparent abnormal findings on sperm were observed in groups 
treated with clomiphene and 0.9% sodium chloride. However, the groups of mice 
that were treated with 50, 100 and 200 mg/kg of extract showed an apparent 
deformity in the form of swelling at the middle tail region as shown in Figure 5.
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Figure 1. Effect of short-term ingestion of 
the methanolic extract Mitragyna speciosa on 
sperm count (x106 sperm/mL) in mice. Values 
are mean ± S.E.M (n=10). * Significantly 
different from 0.9% NaCl-treated group 
(P<0.05) and # significantly different from 
clomiphene-treated group (P<0.05), as 
determined by ANOVA followed by Tukey’s 
test. 
Figure 2. Effect of short-term ingestion of the 
methanolic extract of Mitragyna speciosa on 
sperm motility (%) in mice. Values are mean 
± S.E.M (n=10). * Significantly different 
from 0.9% NaCl-treated group (P<0.05) and # 
significantly different from clomiphene-treated 
group (P<0.05), as determined by ANOVA 
followed by Tukey’s test. 
Figure 3. Effect of short-term ingestion of the methanolic extract of Mitragyna speciosa on the 
testicular weight (mg) of mice 14 days post-treatment. Values are mean ± S.E.M (n=10).
* Significantly different from 0.9% NaCl-treated group (P<0.05) and # significantly different 
from clomiphene-treated group (P<0.05), as determined by ANOVA followed by Tukey’s test.
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Figure 4. Effect of short-term ingestion of 0.9% 
NaCl or clomiphene on the morphology of 
mouse sperm. Eosin-nigrosin, (400x). Sperms 
appeared normal with no marked change in 
morphology
Figure 5. Effect of short-term ingestion 
of the methanolic extract of Mitragyna 
speciosa on the morphology of mouse sperm. 
Eosin-nigrosin, (400x). Arrow indicates 
the deformity in the form of swelling at the 
middle tail region of mouse sperm.
Discussion
In this study, the effect of short-term ingestion of MS extract showed an increase 
in sperm count in mice compared to control groups fed with NaCl (0.9%) and 
clomiphene. The results from this study also showed that there was a slight 
difference in weight of epididymes in control and treatment groups. Increase in the 
sperm count and weight of epididymes could be due to stimulation of endocrine 
system specifically the testis which resulted in increased spermatogenesis and 
consequently increased testosterone level. In addition, there may be a possible 
simultaneous stimulation of the hypothalamus and the pituitary gland to produce 
luteinizing hormone and follicle-stimulating hormone (Guay et al., 2003) and thus, 
signals the testicles to produce testosterone and possibly more sperm through the 
hypothalamus-pituitary-gonadotropin axis. A possible explanation for the observed 
effect could be due to the synergistic effects of various secondary metabolites 
present in the MS leaves on these structures and not due to the effects of MS on 
opioid receptors. It is well-known that opiates inhibit gonadotropin secretion in 
experimental animals and humans (Pfeiffer and Herz, 1984). In addition, exogenous 
and endogenous opioids inhibit sexual arousal and erectile function in experimental 
animal and humans (McIntosh et al, 1980: Cushman, 1972). Morphine addiction 
for example, has been associated with suppression of male and female LH-gonadal 
axis (Cicero et al., 1979). Moreover, chronic exposure to morphine in cell cultures 
showed reduced basal and GnRH (gonadotropin releasing hormone) – stimulated 
LH release (Blank et al., 1986). Since MS has been classified as an opioid and 
resembles morphine in terms of pharmacological properties and function, it is 
believed that the effect on sperm produced by short-term intake of MS could be 
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mediated by a similar mechanism. However, results obtained from this study were 
in contrast to this theory. However, the possible explanation for the opposite effects 
observed could not be determined through this present study.
 Conversely, the unexpected results showed by short-term ingestion of 
clomiphene on the sperm motility and count analyses could be due to the short 
duration (14) of clomiphene intake. A more accurate result may be obtained from 
the study if this drug given for a longer period as clomiphene has been shown to 
increase fertility rate only after 3-6 mo of daily intake (Srivannaboon et al., 1992; 
Schellen, 1982).
 Human sperm cells contain µ-opioid receptors (MOR) (Albrizio et al., 2006). 
In males, MOR-1 gene mutation results in decreased mating behavior, sperm 
motility and reduced litter size (Agirregoitia et al., 2006). Mitragynine, an alkaloid 
from MS leaves has been shown to possess an affinity towards µ-, κ- and δ- opioid 
receptors (Yamamoto et al., 1999). Moreover, studies have demonstrated that 
gonadotropin have opiate receptors of relative high affinity and high capacity (5 
x 104 sites/cell) (Fabbri et al, 1985). It is probable that the compounds present 
in MS extract may bind to the µ- opioid receptor and thus inducing mutation in 
the gene and eventually caused a deformity in the morphology of the sperm at 
the mid tail region. However, the exact mechanism by which MS extract induces 
sperm deformity could not be determined at present. Despite this, the motility of 
sperm especially in groups treated with 100 and 200 mg/kg of MS extract was not 
affected.
Conclusion
In this study, the groups of mice treated with the methanolic extract of Mitragyna 
speciosa at the dosage of 100 and 200 mg/kg showed a marked increase in sperm 
count and sperm motility. The effects seen could be due to the enhancement of 
spermatogenesis through the stimulation of hypothalamus-pituitary-gonadotropin 
axis by the compounds or metabolites present in MSM. A marked increase 
in testicular size and weight could also be explained by the increase in sperm 
concentration which may be stimulated by similar mechanism stated previously. 
However as the doses increased, the occurrence of the deformity of the sperm at 
the middle of the tail region increased simultaneously. The precise mechanism 
underlying this effect has yet to be determined and currently under investigation, 
but it is likely to be associated with genetic mutations involving the interaction of 
MSM with the opioid receptors on the surface of each sperm. 
Effect of Short-Term Ingestion of the Methanolic Extract of Mytragyna Speciosa 57
References
Agirregoitia, E., Valdivia, A., Carracedo, A., Casis, L., Gil, J., Subiran, N., Ochoa, C. 
and Irazusta, J. (2006). Expression and localization of delta-, kappa-, and mu-opioid 
receptors in human spermatozoa and implications for sperm motility. J Clin Endocrinol 
Metab 91(12): 4969-4975.
Albrizio, M., Guaricci, A. C., Calamita, G., Zarrilli, A., and Minoia, P. (2006). Expression 
and immunolocalization of the mu-opioid receptor in human sperm cells. Fertil Steril 
86(6): 1776-1779.
Blank, M. S., Fabbri, A., Catt, K. J. and Dufau, M. L. (1986). Inhibition of luteinizing 
hormone release by morphine and endogenous opiates in cultured pituitary cells. 
Endocrinology 118(5): 2097-2101.
Brugh, V. M. and Lipshultz, L. I. (2004). Male factor infertility: evaluation and management. 
Med Clin North Am 88(2): 367-385.
Cicero, T. J., Schainker, B. A. and Meyer, E. R. (1979). Endogenous opioids participate in the 
regulation of the hypothalamus-pituitary-luteinizing hormone axis and testosterone’s 
negative feedback control of luteinizing hormone. Endocrinology 104(5): 1286-1291.
Cushman, P., Jr. (1972). Sexual behavior in heroin addiction and methadone maintenance. 
Correlation with plasma luteinizing hormone. N Y State J Med  72(11): 1261-1265.
Fabbri, A., Tsai-Morris, C. H., Luna, S., Fraioli, F. and Dufau, M. L. (1985). Opiate 
receptors are present in the rat testis. Identification and localization in Sertoli cells. 
Endocrinol 117(6): 2544-2546.
Guay, A. T., Jacobson, J., Perez, J. B., Hodge, M. B. and Velasquez, E. (2003). Clomiphene 
increases free testosterone levels in men with both secondary hypogonadism and 
erectile dysfunction: who does and does not benefit? Int J Impot Res 15(3): 156-165.
McIntosh, T. K., Vallano, M. L. and Barfield, R. J. (1980). Effects of morphine, beta-
endorphin and naloxone on catecholamine levels and sexual behavior in the male rat. 
Pharmacol Biochem Behav 13(3): 435-441.
Pfeiffer, A. and Herz, A. (1984). Endocrine actions of opioids. Horm Metab Res 16(8): 
386-397.
Schellen, T.M.C.M. (1982). Clomiphene treatment in male infertility. Int J Fertil 27(3):136-
45.
Srivannaboon, S., Dhall, G.I., De Krester, D.M., Hargreave, T.B., Comhaire, F.H., Padron, 
R.S., Mas, J. and Hazelden, C. (1992). A double-blind trial of clomiphene citrate for 
the treatment of idiopathic male infertility. Int J Androl 15 (4):299-307.
Yamamoto, L. T., Horie, S., Takayama, H., Aimi, N., Sakai, S., Yano, S., Shan, J., Pang, 
P.K., Ponglux, D. and Watanabe, K.  (1999). Opioid receptor agonistic characteristics 
of mitragynine pseudoindoxyl in comparison with mitragynine derived from Thai 
medicinal plant Mitragyna speciosa. Gen Pharmacol 33(1): 73-81.
